Treatment increased anti-tumor cytokines (GM-CSF, IL-12, IFN-γ), decreased pro-tumorigenic cytokines (IL-8, VEGF), and activated antigen-presenting cells and CD8+ T cells. This evidence concerns the gene CSF2 and neoplasm.